The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma
- PMID: 21775121
- DOI: 10.1016/j.jnutbio.2011.02.015
The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma
Abstract
Previous studies suggested that curcumin is a potential agent against glioblastomas (GBMs). However, the in vivo efficacy of curcumin in gliomas remains not established. In this work, we examined the mechanisms underlying apoptosis, selectivity, efficacy and safety of curcumin from in vitro (U138MG, U87, U373 and C6 cell lines) and in vivo (C6 implants) models of GBM. In vitro, curcumin markedly inhibited proliferation and migration and induced cell death in liquid and soft agar models of GBM growth. Curcumin effects occurred irrespective of the p53 and PTEN mutational status of the cells. Interestingly, curcumin did not affect viability of primary astrocytes, suggesting that curcumin selectivity targeted transformed cells. In U138MG and C6 cells, curcumin decreased the constitutive activation of PI3K/Akt and NFkappaB survival pathways, down-regulated the antiapoptotic NFkappaB-regulated protein bcl-xl and induced mitochondrial dysfunction as a prelude to apoptosis. Cells developed an early G2/M cell cycle arrest followed by sub-G1 apoptosis and apoptotic bodies formation. Caspase-3 activation occurred in the p53-normal cell type C6, but not in the p53-mutant U138MG. Besides its apoptotic effect, curcumin also synergized with the chemotherapeutics cisplatin and doxorubicin to enhance GBM cells death. In C6-implanted rats, intraperitoneal curcumin (50 mg kg(-1) d(-1)) decreased brain tumors in 9/11 (81.8%) animals against 0/11 (0%) in the vehicle-treated group. Importantly, no evidence of tissue (transaminases, creatinine and alkaline phosphatase), metabolic (cholesterol and glucose), oxidative or hematological toxicity was observed. In summary, data presented here suggest curcumin as a potential agent for therapy of GBMs.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
NFκB inhibitors induce cell death in glioblastomas.Biochem Pharmacol. 2011 Feb 1;81(3):412-24. doi: 10.1016/j.bcp.2010.10.014. Epub 2010 Oct 30. Biochem Pharmacol. 2011. PMID: 21040711
-
Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling.Invest New Drugs. 2012 Dec;30(6):2252-62. doi: 10.1007/s10637-012-9804-z. Epub 2012 Feb 28. Invest New Drugs. 2012. PMID: 22367315
-
Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.Int J Oncol. 2007 Apr;30(4):905-18. Int J Oncol. 2007. PMID: 17332930
-
Therapeutic potentials of curcumin in the treatment of glioblstoma.Eur J Med Chem. 2020 Feb 15;188:112040. doi: 10.1016/j.ejmech.2020.112040. Epub 2020 Jan 7. Eur J Med Chem. 2020. PMID: 31927312 Review.
-
Modulation of Biological Activities in Glioblastoma Mediated by Curcumin.Nutr Cancer. 2019;71(8):1241-1253. doi: 10.1080/01635581.2019.1604978. Epub 2019 Apr 22. Nutr Cancer. 2019. PMID: 31007066 Review.
Cited by
-
Investigating the therapeutic role and molecular biology of curcumin as a treatment for glioblastoma.Ther Adv Med Oncol. 2016 Jul;8(4):248-60. doi: 10.1177/1758834016643518. Epub 2016 Apr 25. Ther Adv Med Oncol. 2016. PMID: 27482284 Free PMC article.
-
Curcumin and Cancer.Nutrients. 2019 Oct 5;11(10):2376. doi: 10.3390/nu11102376. Nutrients. 2019. PMID: 31590362 Free PMC article. Review.
-
Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas.J Neurooncol. 2013 Jul;113(3):385-96. doi: 10.1007/s11060-013-1148-9. Epub 2013 May 11. J Neurooncol. 2013. PMID: 23666203
-
Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas.Int J Mol Sci. 2022 Mar 20;23(6):3360. doi: 10.3390/ijms23063360. Int J Mol Sci. 2022. PMID: 35328780 Free PMC article. Review.
-
Cytotoxicity Mechanisms of Blue-Light-Activated Curcumin in T98G Cell Line: Inducing Apoptosis through ROS-Dependent Downregulation of MMP Pathways.Int J Mol Sci. 2023 Feb 14;24(4):3842. doi: 10.3390/ijms24043842. Int J Mol Sci. 2023. PMID: 36835252 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
